Stephen G. Jones

Assistant Professor

UAMS

Also affiliated: Centers for Disease Control and Prevention (2015); United States Fish and Wildlife Service (2005); Vanderbilt University (2015); Sherwood Forest Hospitals NHS Foundation Trust (2015–2024); Schaffner (Switzerland) (2015); Queen's Medical Centre (2002); BlueCross BlueShield of South Carolina Foundation (2009–2016); Manor Hospital (2009); Mass General Brigham (2019)

Peds Pediatrics, College of Medicine

11 h-index 43 pubs 475 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Stephen G. Jones, an Assistant Professor at the University of Arkansas for Medical Sciences, focuses his research on public health and epidemiological studies. His work has investigated the spatial implications of data analysis methods in healthcare research, including the influence of spatial resolution on disease cluster detection. Jones has also examined demographic factors affecting emergency department utilization within Medicaid populations and explored the clinical utility of advanced microbiology testing tools. He has published 43 papers, accumulating 475 citations and an h-index of 11. His collaborations include several shared publications with researchers at the University of Arkansas for Medical Sciences, such as Stacie M. Jones, Fatimah Al‐Doori, Matthew Bell, and John Alberty.

Metrics

h-index: 11
Publications: 43
Citations: 475

Positions

Assistant Professor publications 2025

University of Arkansas for Medical Sciences Peds Pediatrics, College of Medicine Institutional directory
University of Arkansas for Medical Sciences publications 2025

Pediatrics ORCID

Selected Publications

Incidental Detection of Acute Leukemia During Genetic Evaluation of Neurodevelopmental Disorder in a Pediatric Clinic: A Case Report (2026)

Case Reports in Pediatrics DOI OpenAlex
Trofinetide-Induced Enterocolitis Syndrome in a Child with Rett Syndrome (2025)

Journal of Child Neurology DOI OpenAlex
Potential neonatal toxicity of new psychoactive substances (2023)

Pharmacology & Therapeutics 14 citations DOI OpenAlex
Prediction of milk plasma ratio for amphoteric substances (2022)

Pharmacology Research & Perspectives 3 citations DOI OpenAlex
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1H‐indole‐3‐carboxamide (STS‐135) (2020)

Pharmacology Research & Perspectives 9 citations DOI OpenAlex
Comparaisons continentales des caractéristiques des patients dans PALISADE, étude de phase 3 d’AR101 dans l’allergie à l’arachide (2019)

Revue française d'allergologie DOI OpenAlex
Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22) (2019)

Xenobiotica 4 citations DOI OpenAlex
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial (CoFAR) (2012)

Journal of Allergy and Clinical Immunology 3 citations DOI OpenAlex